Abstract:T cells play important roles in the pathogenesis of inflammatory bowel diseases (IBD). And ubiquitination and deubiquitination are important epigenetic modifications in immune responses. The process of how USP16 (ubiquitin carboxyl-terminal hydrolase 16) regulates the intestinal inflammation has never been explored. USP16 expression in isolated PBMCs and intestinal tissues of IBD patients and healthy controls were examined by quantitative real-time PCR (qRT-PCR) and immunohistochemistry respectively. T-cell-specific USP16 knockout mouse was generated with the Cre/LoxP technology. Colitis was induced in Rag1−/− mice by transfer of CD4+CD25-CD45RBhi T cells from C57/Bl6 or transgenic mice. T cells were isolated from mice, and the T-cell characteristics were analysed by flow cytometry and qRT-PCR. We used western blot and calcium flux to seek for the substrate of USP16, and immunoprecipitation and immunofluorescence were used to confirm the interaction. Plasmid transfection to the HEK293T cells and mass spectrometry were used to find the ubiquitinated point on the substrate. IBD patients and inflamed intestinal tissues have higher levels of USP16 than controls. T-cell-specific USP16-knockout mice exhibited less severe colitis and less CD4+ T cells infiltration than the C57/Bl6 mice. USP16-deficient T cells had homeostasis dysregulation, impaired proliferation, defected differentiation, and normal migration ability. The calcium-triggered deubiquitination of calcineurin A (CNA), encoded by Ppp3cb or Ppp3cc, in a manner consistent with these defects. We found that the CNA is constitutively ubiquitinated on lysine 327 and that the resulting polyubiquitin chain is rapidly removed by USP16 in response to intracellular calcium stimulation. The K29-linked ubiquitination of CNA impaired NFAT recruitment and the transcription of NFAT-targeted genes. Our work elucidates the physiological function of calcineurin ubiquitination and its deubiquitinase USP16 in peripheral T cells. Notably, our results provide a critical mechanism for the regulation of calcineurin activity and a novel immunosuppressive drug target for the treatment of IBD.

USP4 Interacts and Positively Regulates IRF8 Function Via K48-linked Deubiquitination in Regulatory T Cells.

Ubiquitin Specific Peptidase 4 Stabilizes Interferon Regulatory Factor Protein and Promotes Its Function to Facilitate Interleukin-4 Expression in T Helper Type 2 Cells.

Cutting Edge: Ubiquitin-Specific Protease 4 Promotes Th17 Cell Function under Inflammation by Deubiquitinating and Stabilizing RORγt

USP1-regulated Reciprocal Differentiation of Th17 Cells and Treg Cells by Deubiquitinating and Stabilizing TAZ.

The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation

USP12 promotes CD4+ T cell responses through deubiquitinating and stabilizing BCL10

Usp4 Positively Regulates Rig-I-Mediated Antiviral Response Through Deubiquitination and Stabilization of Rig-I

Deubiquitinase USP4 Suppresses Antitumor Immunity by Inhibiting IRF3 Activation and Tumor Cell-Intrinsic Interferon Response in Colorectal Cancer

USP21 Prevents the Generation of T-helper-1-like Treg Cells

USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.

Ubiquitin-specific peptidase 18 regulates the differentiation and function of Treg cells

P037 USP16-mediated deubiquitination of calcineurin A controls peripheral T cells maintenance and attenuates intestinal inflammation

USP4 targets TAK1 to downregulate TNF|[alpha]|-induced NF-|[kappa]|B activation

Ubiquitin-specific Protease 4 Mitigates Toll-like/Interleukin-1 Receptor Signaling and Regulates Innate Immune Activation*

Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3.

USP3 Inhibits Type I Interferon Signaling by Deubiquitinating RIG-I-like Receptors

USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination Through NLRP4 Signalosome.

Ubiquitin-Specific Protease 4 (Usp4) Targets Traf2 And Traf6 For Deubiquitination And Inhibits Tnf Alpha-Induced Cancer Cell Migration

USP4 Inhibits P53 and NF-κB Through Deubiquitinating and Stabilizing HDAC2

Regulation of T Cell Function by the Ubiquitin-Specific Protease USP9X Via Modulating the Carma1-Bcl10-Malt1 Complex.

Regulation of TRIF-mediated innate immune response by K27-linked polyubiquitination and deubiquitination